Earnings Roundup: 11 Top NYSE Stocks to Analyze After Earnings

Top Dow (NYSE:DIA) and S&P 500 (NYSE:SPY) stocks on the NYSE (NYSE:NYX) announced earnings this week. Here’s your Cheat Sheet to their announcements and business outlooks:

Must Read Feature: Here’s Why Chipotle is a Shareholder’s Dream Stock.

Exxon-Mobil (NYSE:XOM): The leading oil company reported its results for the second fiscal quarter today, with net income rising to $10.7 billion ($2.18 per share) vs. $7.56 billion ($1.60 per share) in the same quarter a year earlier. This marks a rise of 41.5% from the year earlier quarter.  XOM fell short of the mean analyst estimate of $2.34 per share. The stock closed down -2.22%.

Bristol-Myers Squibb (NYSE:BMY): The worldwide pharmaceutical developer published the results of its second quarter today. Net income for the drug manufacturer fell to $902 million (52 cents per share) vs. $927 million (53 cents per share) a year earlier. This is a decline of 2.7% from the year earlier quarter. Revenues rose 14% to $5.43 billion from the year earlier quarter. BMY reported adjusted net income of 56 cents per share. By that measure, the company beat the mean estimate of 55 cents per share. It beat the average revenue estimate of $5.04 billion. The stock ended up 1.54% in trading.

“I am proud of this organization and our strong second quarter results across the board-financially, clinically, and operationally. This performance demonstrates the success of our BioPharma strategy in delivering short term results and in positioning the Company for the future,” said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb. “While we delivered double-digit sales growth during the second quarter, driven in part by the strong initial performance of YERVOY (ipilimumab), we also received regulatory approval for NULOJIX (belatacept) in the U.S. and Europe, and ELIQUIS in Europe for VTE prevention. That brings us to three new products approved in three months, including the approval of YERVOY in the U.S. in March. We also presented clinical data from our oncology and diabetes franchises, and announced important positive top line results from our Phase III ARISTOTLE trial on ELIQUIS for stroke prevention in patients with atrial fibrillation.”

Kellogg Company (NYSE:K): The cereal and convenience food-maker reported its earnings for the second quarter. Net income rose to $343 million (94 cents per share) vs. $302 million (79 cents per share) in the same quarter a year earlier. This marks a rise of 13.6% from the year earlier quarter. Revenue rose 10.6% to $3.39 billion from the year earlier quarter. The company beat the mean analyst estimate of 91 cents per share. It beat the average revenue estimate of $3.29 billion. K stock traded up 0.49% by the closing bell.

“We continue to build momentum as demonstrated by our solid first half top-line results. During the second quarter, we benefited from improved net price realization and were pleased with the performance of our strong innovation,” said John Bryant, Kellogg Company’s president and chief executive officer. “As we look to the back half of 2011, we expect continued sales growth driven by price and mix and are confident in our innovation line up and commercial plans.”

MetLife Inc. (NYSE:MET): The insurance company reported its second quarter results, with net income for falling to $1.2 billion ($1.13 per share) vs. $1.56 billion ($1.84 per share) a year earlier. This is a decline of 22.9% from the year earlier quarter. Revenue rose 21.3% to $17.15 billion last quarter. MET beat the mean analyst estimate of $1.11 per share. It beat the average revenue estimate of $16.12 billion. The stock gained 3.42% in after hours trades.

“MetLife delivered strong results during the second quarter,” said Steven A. Kandarian, president and chief executive officer of MetLife, Inc. “We grew earnings per share by 13% over the prior-year quarter while generating a record $11.8 billion in premiums, fees and other revenues. The fact that we were able to deliver these results despite losses from natural disasters in the United States and Japan is a testament to the earnings power of MetLife’s diverse portfolio of businesses. Our Alico integration work is proceeding on plan, and we’re well positioned for continued profitable growth that adds shareholder value.”

Chesapeake Energy Corporation (NYSE:CHK): Chesapeake Energy Corp. is a company that explores and develops properties for the production of crude oil and natural gas from underground reservoirs. It reported earnings for the second fiscal quarter today. Net income for the independent oil and gas company rose to $510 million (68 cents per share) vs. $255 million (37 cents per share) in the same quarter a year earlier. This is a twofold rise from the year earlier quarter. Revenues rose 64.9% to $3.32 billion from the year earlier. CHK reported adjusted net income of 76 cents per share. By that measure, it beat mean analyst estimate of 72 cents per share. It beat the average revenue estimate of $2.76 billion. The stock has risen 1.29% in after hours trades.

AFLAC Inc. (NYSE:AFL): The insurance company reported its second quarter results, with net income falling to $280 million (60 cents per share) vs. $581 million ($1.23 per share) a year earlier. This is a decline of 51.8% from the year earlier quarter. Revenues rose 2.2% to $5.09 billion from the year earlier. AFLs operating income, which takes into account special items, was $1.56 per share beating the mean analyst estimate of $1.54 per share. It fell short of the average revenue estimate of $5.69 billion. AFL stock was up 4.42% in premarket trading.

Chairman and Chief Executive Officer Daniel P. Amos stated: “We are pleased with our overall results in the second quarter of 2011. Aflac Japan overcame challenges resulting from the most destructive and devastating natural disaster in Japan’s history, to achieve strong sales growth.”

Delta Airlines (NYSE:DAL): The large U.S. air carrier reported earnings for the second fiscal quarter this morning. Net income for the airline fell to $198 million (23 cents per share) vs. $467 million (55 cents per share) a year earlier. This is a decline of 57.6% from the year earlier quarter. Revenue rose 12.1% to $9.15 billion from the year earlier quarter. DAL reported adjusted net income of 43 cents per share. By that measure, the company fell short of mean estimate of 48 cents per share. Analysts were expecting revenue of $9.16 billion. “High fuel prices are putting significant pressure on the industry, but the benefits of Delta’s strategic actions and the dedication of Delta employees are evident in the solid profit we produced despite more than $1 billion in higher fuel expense,” said Richard Anderson, Delta’s chief executive officer. “Our revenue momentum, coupled with the capacity reductions we are making in September and actions to get our non-fuel costs to 2010 levels, will generate the margins we need to hit our return targets.” DAL stock closed down -5.11% today.

The Boeing Company (NYSE:BA): The leading US aerospace company reported its second quarter results earlier, with net income rising to $941 million ($1.25 per share) vs. $787 million ($1.06 per share) in the same quarter a year earlier. This marks a rise of 19.6% from the year earlier quarter. Revenue rose 6.2% to $16.54 billion from the year earlier quarter. The company beat the mean analyst estimate of 96 cents per share. Analysts were expecting revenue of $16.41 billion.“Strong operational performance drove double-digit margins at both of our major businesses and produced outstanding results in the quarter,” said Jim McNerney, Boeing chairman, president and chief executive officer.”We also made major progress toward certification and delivery of the 787 Dreamliner and 747-8 and continued our disciplined increases in commercial airplane production rates.Our outlook for the year has strengthened as our team continues its relentless focus on productivity improvement, cash management and program execution.” BA stock posted gains of 0.67% by the closing bell.

Texas Instruments (NYSE:TXN): The company, which designs and makes semiconductors that it sells to electronics designers and manufacturers all over the world, reported its second quarter earnings today, with net income falling to $672 million (56 cents per share) vs. $769 million (62 cents per share) a year earlier. This is a decline of 12.6% from the year earlier quarter. Revenue also fell 1% to $3.46 billion from the year earlier quarter. TXN beat the mean analyst estimate of 53 cents per share. Analysts were expecting revenue of $3.44 billion.

“We are pleased with the continued success of the TI portfolio in Analog and Embedded Processing. Sequential revenue growth was driven by Embedded Processing up 12 percent and Analog up three percent, andwe believe we again gained market share in both segments,” said Rich Templeton, TI’s chairman, president and chief executive officer. “In the quarter, we also resumed production ahead of schedule at our Japan factories that were damaged in the earthquake, thanks to excellent work by our teams on the ground.”

Kimberly Clark Corp. (NYSE:KMB): The manufacturer and marketer of arrange of mostly paper-based consumer products reported its second quarter earnings today, with net income falling to $408 million ($1.03 per share) vs. $498 million ($1.20 per share) a year earlier. This is a decline of 18.1% from the year earlier quarter. Revenues rose 8.3% to $5.26 billion from the year earlier quarter. The company reported adjusted net income of $1.18 per share. By that measure, it beat the mean estimate of $1.15 per share. It beat the average revenue estimate of $5.13 billion. KMB stock is up .24% in after hours trades.

Chairman and Chief Executive Officer Thomas J. Falk said, “Our organic sales grew in the second quarter in line with our full-year plan, as we continue to benefit from innovation and targeted growth initiatives. We are gaining market share in a number of businesses and are launching additional product innovations to further improve our brands. We also continue to deliver significant ongoing cost savings and generate strong cash flow. Although adjusted earnings per share were down slightly in the second quarter versus last year, we delivered sequential improvement in most key metrics compared to the first quarter, which gives us added confidence in our performance in the back half of the year.”

Competitors to Watch: The Procter & Gamble Co. (NYSE:PG), Colgate-Palmolive (NYSE:CL), Clorox (NYSE:CLX), and Johnson & Johnson (NYSE:JNJ).

Baker Hughes Inc. (NYSE:BHI): The provider of products and services for the drilling and evaluation of oil and gas wells as well as fluids and chemicals and reservoir technology reported second quarter earnings today, with net income rising to $338 million (77 cents per share) vs. $93 million (23 cents per share) in the same quarter a year earlier. This is a more than threefold rise from the year earlier quarter. Revenues also jumped 40.5% to $4.74 billion from the year earlier quarter. BHI stock closed up 0.05% today.

Chad C. Deaton, Baker Hughes chairman and chief executive officer, said, “Our performance was solid this quarter with steady improvement of our international profit margin. As expected, the sequential profit improvement in US Land and the Gulf of Mexico nearly offset the seasonal decline in Canada.”

Fresh Off the Press: Wall St. Cheat Sheet’s newest Feature Trades of the Month!